Companies

Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.

  1. Abrdn Australia Equity Fund, Inc.

    The Funds principal investment objective is longterm capital appreciation through investment primarily in equity securities of Australian companies listed on the Australian Stock Exchange Limited ASX. The Funds secondary investment objective is current income.

    IAF
  2. Abrdn Emerging Markets Ex-china Fund, Inc.

    The Fund seeks to provide both current income and longterm capital appreciation. The fund invests primarily in Chilean equity & debt securities. It is the policy of the Fund normally to invest at least 80% of total assets both in Chilean equity and debt securities, although under normal market conditions most investments will be in equity securities.

    AEF
  3. Abrdn Global Dynamic Dividend Fund

    Alpine Global Dynamic Dividend Fund is a United States based diversified closedend management investment company.

    AGD
  4. Abrdn Global Income Fund, Inc.

    The Funds principal investment objective is to provide high current income by investing primarily in fixedincome securities. As a secondary investment objective the Fund seeks capital appreciation but only when consistent with its principal investment objective.

    FCO
  5. Abrdn Global Infrastructure Income Fund

    Aberdeen Standard Global Infrastructure Income Fund (the Fund) is a newly organized, non-diversified, closed-end management investment company. The Funds investment objective is to seek to provide a high level of total return with an emphasis on current income. There is no assurance that the Fund will achieve its investment objective The Fund seeks to achieve its investment objective by investing in a portfolio of income-producing public and private infrastructure equity investments around the world. Under normal circumstances, at least 80% of the Funds net assets (plus the amount of any borrowings for investment purposes) will be invested in U.S. and non-U.S. infrastructure-related issuers.

    ASGI
  6. Abrdn Global Premier Properties Fund

    The Funds primary investment objective is to seek capital appreciation with secondary objective of high current income.

    AWP
  7. Abrdn Gold Etf Trust

    No description

    SGOL
  8. Abrdn Healthcare Investors

    Tekla Healthcare Investors is a United States based nondiversified closedend management investment company. Its objective is to seek longterm capital appreciation by investing primarily in securities of healthcare companies.

    HQH
  9. Abrdn Healthcare Opportunities Fund

    Tekla Healthcare Opportunities Fund is a nondiversified closedend fund. The funds objective is to seek current income and longterm capital appreciation through investing in companies engaged in the healthcare industry.

    THQ
  10. Abrdn Income Credit Strategies Fund

    The Funds primary investment objective is to seek a high level of current income with a secondary objective ofcapital appreciation.

    ACP
  11. Abrdn Japan Equity Fund, Inc.

    Aberdeen Japan Equity Fund Inc is a United States based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis.

    JEQ
  12. Abrdn Life Sciences Investors

    Tekla Life Sciences Investors is a United States based closedend management investment company. Its investment objective is to seek longterm capital appreciation by investing primarily in the securities of life sciences companies.

    HQL
  13. Abrdn National Municipal Income Fund

    Delaware Investments Natl Muni Income is a closed-end investment fund.

    VFL
  14. Abrdn Palladium Etf Trust

    No description

    PALL
  15. Abrdn Platinum Etf Trust

    No description

    PPLT
  16. Abrdn Precious Metals Basket Etf Trust

    No description

    GLTR
  17. Abrdn Silver Etf Trust

    No description

    SIVR
  18. Abrdn Total Dynamic Dividend Fund

    Alpine Total Dynamic Dividend Fund is a diversified closedend management investment company. Its investment objective is to seek high current dividend income and also focuses on longterm growth of capital.

    AOD
  19. Abrdn World Healthcare Fund

    Tekla World Healthcare Fund is a closed end fund. Its objective is to provide a high level of current income and longterm capital appreciation. Trust expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities and debt securities. Managed Assets means the total assets of the Trust minus the sum of the Trusts accrued liabilities. The Trusts 80% policy may only be changed with 60 days prior notice to the Trusts shareholders. The Trust will concentrate its investments in the healthcare industries. No assurance can be given that the Trust will achieve its investment objective.

    THW
  20. Absci Corp

    Absci is advancing the future of drug discovery with generative design to create better biologics for patients, faster. Our Integrated Drug Creation platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci's approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Each cycle refines our data and strengthens our models, facilitating rapid innovation and enhancing the precision of our therapeutic designs. Alongside collaborations with top pharmaceutical, biotech, tech, and academic leaders, Absci is advancing its own pipeline of AI designed therapeutics including ABS-201, a groundbreaking innovation in hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern hair-loss.

    ABSI
  21. Abvc Biopharma, Inc.

    ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes that represent enormous commercial potential.

    ABVC
  22. Ac Immune Sa

    AC Immune SA is a clinical-stage biopharmaceutical company and a global leader in precision prevention for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and NeuroOrphan indications driven by misfolded proteins. The Company's two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features a range of therapeutic and diagnostic programs, including candidates in Phase 2 and Phase 3 development. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive funding to advance its proprietary programs and >$4.5 billion in potential milestone payments plus royalties.

    ACIU
  23. Ac Partners, Inc.

    AC Partners, Inc., headquartered in Palm City Florida, engages in the design, sale, maintenance and installation of central air conditioning systems for commercial and residential customers ACPI is an authorized dealership for Rheem, American Standard, Goodman and Amana air conditioning systems. ACPI's primary focus is to grow through strategic acquisitions and maximize our customers and partnerships.

    ACPS
  24. Acacia Research Corp

    Acacia (Nasdaq: ACTG ) is a publicly traded company that is focused on acquiring and operating attractive businesses across the industrial, energy and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.

    ACTG
  25. Academy Sports & Outdoors, Inc.

    Academy is a leading full-line sporting goods and outdoor recreation retailer in the United States. Originally founded in 1938 as a family business in Texas, Academy has grown to more than 300 stores across 21 states and counting. Academy's mission is to provide "Fun for All" and Academy fulfills this mission with a localized merchandising strategy and value proposition that strongly connects with a broad range of consumers. Academy's product assortment focuses on key categories of outdoor, apparel, sports & recreation and footwear through both leading national brands and a portfolio of private label brands.

    ASO
  26. Acadia Healthcare Company, Inc.

    Acadia is a leading provider of behavioral healthcare services across the United States (the "U.S."). As of September 30, 2025, Acadia operated a network of 278 behavioral healthcare facilities with approximately 12,500 beds in 40 states and Puerto Rico. With approximately 25,500 employees serving more than 82,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

    ACHC
  27. Acadia Pharmaceuticals Inc

    Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we're here to be their difference.

    ACAD
  28. Acadia Realty Trust

    Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth. Acadia owns and operates a high-quality core real estate portfolio ("REIT Portfolio") of street and open-air retail properties in the nation's most dynamic retail corridors, along with an investment management platform that targets opportunistic and value-add investments through its institutional co-investment vehicles ("Investment Management").

    AKR
  29. Acadian Asset Management Inc.

    Acadian Asset Management Inc. is the NYSE listed holding company of Acadian Asset Management LLC, with approximately $166 billion of assets under management as of September 30, 2025. Acadian offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.

    AAMI
  30. Acap Strategic Fund

    No description

    XCAPX